1. An overview of the mechanisms of HIV-1 infection, latency, pathogenesis, and eradication strategies from the CNS 2. Central Nervous System Complications of Human Immunodeficiency Virus Infection 3. Health LIteracy in HIV-associated Neurocognitive Disorders 4. Neuroimaging insights into the CNS effects of HIV infection 5. Early and upstream subcellular organellar events associated with HAND 6. White matter loss and oligodendrocyte dysfunction in HAND 7. Pathogenesis of HIV-associated pain 8. Neuropathogenesis of HIV-associated neuropathic pain 9. Neuropathic Pain in HIV and the role of the Autophagy pathway 10. Host peripheral immune dynamics increase HIV-associated neurocognitive disorders incidence and progression 11. The role of immunometabolism in HIV associated depression and cognitive impairment 12. Role of extracellular viral regulatory proteins in neuropathogenesis 13. Role of inflammasomes in HIV-1 and drug abuse-mediated neuroinflammation 14. The Contribution of Myeloid Cells to HIV Neuropathogenesis 15. Immunophilin ligands modulate phagocytosis and viral replication in HIV-infected macrophages 16. Immunometabolic mechanisms of HIV-associated neurocognitive disorders and traumatic brain injury: Commonalities and contrasts between chronic and acute neurodegenerative pathologies 17. Endolysosome dysfunction in HAND 18. Evolving biomarkers for HIV-associated neurocognitive disorders (HAND) 19. Intracellular immunity against HIV infection 20. NeuroHIV and the Glymphatic System 21. The p75 neurotrophin receptor: emerging role in the pathogenesis of mature synapses in Human Immunodeficiency Virus-Associated Neurocognitive Disorders 22. The Role of HIV-Associated Neuroendocrine Dysfunction in HAND 23. Impact of SARS-CoV-2/COVID-19 on HIV-1-associated neurocognitive disorders 24. Molecular mechanisms of dopaminergic transmission in NeuroHIV 25. The effect of substance misuse on HIV persistence in the CNS: epidemiological, immunological, and molecular considerations 26. Extracellular vesicles in alcohol- and tobacco-induced neuroAIDS 27. NeuroHIV in the context of opioid use disorder: A complex and evolving relationship 28. Impairment of cholesterol homeostasis induced by Nef-containing extracellular vesicles as a factor in HAND pathogenesis 29. Long noncoding RNAs in immune response, viral infection, and opioid use 30. Using cross-species behavioral tools to determine mechanisms contributing to HIV associated neurological disorders and comorbid substance use 31. Therapeutic potential of Curcumin in treating HIV-1 associated neurocognitive disorders 32. Targeting the Endocannabinoid System in HAND 33. Predicting the effectiveness of combination treatment of Dolutegravir and Fluoxetine for Depressive disorders in HIV 34. ANTIRETROVIRAL THERAPY AND ITS CEREBRAL VASCULAR TOXICITY 35. Strategies for HIV-1 Elimination

Provides an in-depth exploration of the clinical manifestations of HAND and its comorbidities Includes detailed assessments of the molecular and cellular mechanisms underlying HAND symptoms Examines animal models for studying HAND, including macaque and rodent models Presents insights into epigenetic regulation and signaling pathways implicated in HAND Covers prevention, therapeutic strategies, and diagnostic approaches